fbpx PixelServer

Jingle Mingle Raises $650,000 for Innovative Therapies on Vancouver Island

December 2, 2019

BC Cancer Foundation's 2019 Jingle Mingle event
Guests at Jingle Mingle 2019

On November 28, $650,000 was raised at the annual Jingle Mingle event in Victoria. Fueled by the generosity of 325 generous guests, along with several community sponsors, these funds will support the launch of the Innovative Therapies unit at BC Cancer – Victoria.

View the full photo gallery here.

Jingle Mingle raised $650,000 for Innovative Therapies
Thanks to generous donors, $650,000 was raised for Innovative Therapies

The primary goal of the Innovative Therapies unit is to create more clinical trials for patients on Vancouver Island and beyond. Currently, there are six trials available in Victoria, and with the philanthropic support seen at Jingle Mingle, BC Cancer can now quadruple this amount to 24 trials in the next two years.

Linda West - Jingle Mingle Feature Patient
Feature Patient, Linda West (center)

Feature patient and attendee, Linda West, owes her life to the Innovative Therapies unit after her breast cancer diagnosis in 2017. Thanks to the research that allowed clinicians to identify a targeted drug for Linda, she is now living a healthy and happy life.

Set against a festive background, the evening welcomed guest speaker Carla Thomson, who spoke about her 17-year-old daughter, Michelle Reilly, who was diagnosed with Stage IV brain cancer in 2018. Thanks to an immunotherapy drug, Michelle continues to receive the gift of time with her family.

Jingle Mingle Guest Speaker, Carla Thomson
Guest Speaker, Carla Thomson

We extend our deepest thanks to our generous committee for their passion and hard work, as well as our donors, sponsors and volunteers for your support! With you, we are changing cancer outcomes right here in British Columia.

2019 Jingle Mingle Gala Committee
2019 Jingle Mingle Gala Committee

Since starting 13 years ago, Jingle Mingle has raised over $8 million to provide the Island community with world-class cancer research and care.